Community Perceptions of Harm Reduction and Its Implications for Syringe Exchange Policy

AuthorJoshua T. Barnett,Amanda Sharp,Enya B. Vroom
DOI10.1177/0022042620932289
Published date01 October 2020
Date01 October 2020
Subject MatterArticles
https://doi.org/10.1177/0022042620932289
Journal of Drug Issues
2020, Vol. 50(4) 507 –523
© The Author(s) 2020
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/0022042620932289
journals.sagepub.com/home/jod
Article
Community Perceptions of Harm
Reduction and Its Implications
for Syringe Exchange Policy
Amanda Sharp1, Joshua T. Barnett1,2 ,
and Enya B. Vroom1
Abstract
In the United States, the rising prevalence of opioid addiction has led to an increase in opioid-
related overdose deaths and transmission of infectious disease. This resulted in the declaration
of a national public health emergency and the need for harm reduction strategies such as syringe
exchange. Florida has seen increases in blood-borne diseases and fatal/nonfatal opioid overdoses,
yet harm reduction policy integration has been historically limited. To inform policy change, this
study explores the perspectives of community members in Manatee County, Florida, on harm
reduction services. Six focus groups were conducted with findings centralized around three
emergent themes related to the implementation of a syringe exchange program: (a) awareness
and acceptability; (b) facilitating factors; and (c) perceived barriers. The results of this qualitative
research helped to inform the successful adoption of a local syringe exchange ordinance.
Recommendations for community education and engagement regarding harm reduction policy
are discussed.
Keywords
harm reduction, opioid use disorder, syringe exchange, needle exchange, community engagement,
policy
Introduction
Opioid use in the United States is a major public health problem, where rates of prescription
opioids and heroin use has doubled over the last 10 years (Romo et al., 2018). In 2017, opioid-
related overdoses were 6 times higher than in 1999 (Scholl et al., 2019), and in this same year,
one in 10 HIV diagnoses were attributed to injecting drug use (Centers for Disease Control and
Prevention [CDC], 2017b). Florida has led the country as the state with the highest number of
drug overdose deaths (CDC, 2018a), reported the highest rate of AIDS-related deaths in 2016
(CDC, 2018b), and in 2018, led the nation in the number of new HIV cases (CDC, 2019).
1University of South Florida, Tampa, USA
2Manatee County Government, Bradenton, FL, USA
Corresponding Author:
Amanda Sharp, Department of Mental Health Law and Policy, College of Behavioral and Community Sciences,
University of South Florida, 13301 Bruce B. Downs Blvd, MHC2731, Tampa, FL 33612, USA.
Email: amandasharp@usf.edu
932289JODXXX10.1177/0022042620932289Journal of Drug IssuesSharp et al.
research-article2020
508 Journal of Drug Issues 50(4)
Despite the multiple efforts to combat the adverse health effects caused by the opioid crisis in
the United States, additional strategies are needed. Attention has been given to harm reduction-
based approaches to combat the transmission of infectious diseases, promote access to personal
safety measures, and enhance treatment acceptance. As it relates to an addiction treatment frame-
work, harm reduction is an approach that prioritizes safety measures for people who use drugs
with the intention of reducing the personal and population health risks associated with drug use
(Single, 1995). While harm reduction services have largely been advocated for by grassroots
organizations, anti-stigma campaigns, and human rights activists for decades, it was not until
recently that harm reduction approaches have garnered the attention of public health profession-
als and policymakers.
In Florida, harm reduction options have historically been restricted and few options for inno-
vative harm reduction strategies have been embraced in comparison to other states. As these
strategies continue to be considered, public perception is one way to influence the development
and adoption of harm reduction policies. This study highlights one way that community member
perspectives can be leveraged to influence policy around a specific harm reduction measure, the
implementation of syringe exchange programs (SEPs).
Background
As opioid use has increased, consequences such as opioid-related overdose and the spread of
infectious diseases caused by injecting drug use have promulgated the urgency to address the
opioid crisis (Hedegaard et al., 2017; Zibbell et al., 2018). Opioids include illicit substances such
as heroin and fentanyl analogs in addition to prescription pain relievers such as hydrocodone
(e.g., Vicodin), fentanyl, oxycodone (e.g., OxyContin, Percocet), and morphine (e.g., Kadian,
Avinza). A significant number of heroin users initially become addicted to prescribed and/or
nonprescribed opioid medications, but later divert to illicit opioids as the less expensive, more
powerful, and often more available option (Mars et al., 2014).
In the United States, the number of heroin users rose by 50% from 404,000 in 2002 to 828,000
in 2015 (CDC, 2017a; Muhuri et al., 2013). Of the 70,237 drug overdose deaths that occurred in
2017 in the United States, 47,600 of those deaths were caused by opioid-related overdoses which
is the highest number of opioid-related deaths to date (Ahmad et al., 2020). In 2016, opioids
killed more people than either car accidents, gun violence, or breast cancer (Hedegaard et al.,
2017).
In addition to being at increased risk for overdose, people who inject drugs (PWID) are also
at increased risk for blood-borne illnesses such as HIV and viral hepatitis (Des Jarlais et al.,
2001). Latest reports from the CDC estimate that in 2016, over 1.1 million people over the age of
13 are living with HIV in the United States (CDC, 2019). In addition, an adjusted estimate of
44,700 cases of acute hepatitis C occurred from 40 states in 2015, of a total of 2.4 million people
living with the viral infection (CDC, 2017c). According to the CDC, injecting drug use is the
most common means of transmission for hepatitis C in the United States (CDC, 2016). With such
a rapid increase in the prevalence of fatal opioid overdoses and diseases related to injection drug
use, harm reduction strategies offer solutions to reduce these negative trends.
Harm Reduction and Syringe Exchange
Harm reduction represents a series of solutions and interventions aimed at reducing the harm
associated with risky drug use behaviors (Single, 1995). One such method of harm reduction
includes SEPs. SEPs, also known as needle exchange programs (NEPs) or syringe services pro-
grams (SSPs), are social service programs designed to promote public health by providing PWID
the opportunity to obtain sanitary hypodermic needles (and other safe drug use resources) at little

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT